Summary:
- The article discusses the establishment of a specialized clinical program at Johns Hopkins University designed to address and mitigate adverse psychological effects resulting from the use of psychedelic substances.
- It highlights the shift in clinical focus from the therapeutic potential of psychedelics to the necessity of evidence-based protocols for managing "bad trips" and long-term psychological distress, reflecting a maturing field of psychiatric research.